Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
This is particularly relevant for medications with narrow therapeutic windows, such as thyroid hormones and certain antibiotics
Taken together, these studies underscore the potential of gut-targeted therapies in managing the multi-systemic symptoms of CFS/ME
A previous CB1 receptor blocker, Rimonabant, was approved in Europe in 2006 but was discontinued in 2008 owing to serious psychiatric side effects
Cassano T, Magini A et al (2019) Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimers disease
US$ 26.44
US$ 23.14
US$ 28.99
